This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Scientists Solve Mystery About Why HIV Patients are More Susceptible to TB Infection
    A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology they ...More
    June 30, 2009 Posted in News
  • Fighting TB Might be a Matter of 'Flipping a Switch" in Immune Response
    Scientists are focusing on a new concept in fighting airborne pathogens by manipulating what is called the “switching time,” the point at which a highly regulated immune response gives way to powerful cells that specialize in fighting a specific invading bug.In ...More
    June 22, 2009 Posted in News
  • Developing Drugs for Neglected Diseases
    Researchers from Indiana University-Purdue University Indianapolis (IUPUI) have developed Distributed Drug Discovery (D3), a new low-cost strategy to accelerate the discovery of drugs to treat neglected diseases such as tuberculosis, leprosy, leshmaniasis, dengue fever and ...More
    June 15, 2009 Posted in News
  • Nurse Researchers Toil to Curb Spread of Infectious Disease
    Fighting infectious disease, the very heart of public health and the genesis of contemporary nursing, is about more than handwashing and immunizations. It’s about screening and early detection, identifying risk and protective factors, and educating clinicians, ...More
    June 12, 2009 Posted in News
  • Best Ways to Use Standard TB Vaccine
    In a study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Saint Louis University’s Center for Vaccine Development is investigating whether the standard vaccine used in foreign countries against ...More
    June 12, 2009 Posted in News
  • Results from Trial of MDR-TB Drug are Encouraging
    Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today. TMC207 is being developed by Tibotec ...More
    June 3, 2009 Posted in News
  • TB: Hiding in Plain Sight
    Current research suggests that Mycobacterium tuberculosis can evade the immune response. The paper by Rahman et al., "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the ...More
    May 26, 2009 Posted in News, Hand Hygiene, PPE & Standard Precautions
  • U.S. Should Bolster Funding to Improve Public Health
    To fulfill America's humanitarian obligations as a member of the international community and to invest in the nation's long-term health, economic interests, and national security, the United States should reaffirm and increase its commitment to improving the health of ...More
    May 20, 2009 Posted in News
  • Study Suggests TB Screening Needs to be Targeted for Maximum Public Health Benefit
    New estimates of the likelihood that a latent case of tuberculosis (TB) will become active have resulted in a roughly 50 percent increase over previous estimates of the number of people needed to be screened (NNS) to prevent an active infection, limiting the cost ...More
    May 20, 2009 Posted in News
  • Bacteria With a Built-In Thermometer
    Researchers in the Molecular Infection Biology group at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Braunschweig Technical University could now demonstrate for the first time that bacteria of the Yersinia genus possess a unique protein ...More
    May 20, 2009 Posted in News